Home : FDA Drug Database : Accolate : Newsfeeds

Accolate - Newsfeeds

Montelukast in Asthmatic Patients 6 Years-14 Years Old With an FEV^Sub 1^ > 75%*: Am J Respir Crit Care Med 1999; 159:79-86 26. Kemp Jf; Minkwitz MC, Bonuccelli CM, Warren MS. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma. Chest 1999;! 15(2):336-42 27. MacKenzie CA, Weinberg EG ...
Not Getting Enough Vitamin D Can Worsen Asthma: Asthma is one of the most common respiratory diseases, affecting millions of Americans. Inhaled corticosteroids (glucocorticoids) are widely used as the mainstay of maintenance therapy for patients with persistent asthma. Although research has shown that ...
New Products, Findings Breathe Life Into Asthma Market As Companies Expand Drug Development Opportunities: CHEMICAL BLOCKER: Accolate was the first new asthma drug approved by FDA since the 1970s. New research is breathing life into the asthma drug market. Inspired by improving knowledge of asthma's biochemistry, more than 40 companies worldwide are ...
Microsoft Touts FonePlus – PC Substitute for Developing Countries.: Microsoft Corp., the world’s main maker of operating systems and software, has showcased a prototype of a device which can substitute personal computers in the poorest countries. The software giant plans to provide a Windows CE-like operating system for ...
FDA investigates Merck drug-suicide link: S, according to Merck. First approved in 1998, it's part of a class of asthma and allergy drugs that includes AstraZeneca's Accolate and Critical Therapeutics's Zyflo. FDA said it is also reviewing reports of side effects with those drugs. Their labeling ...
FDA probe finds no link with asthma drugs, suicide: The agency launched a probe into the safety of the drug and others in its class, including AstraZeneca PLC's Accolate and Critical Therapeutics Inc.'s Zyflo. Singulair was Whitehouse Station, N.J.-based Merck's best-selling product last year, with expected ...
Merck, AstraZeneca Asthma Drugs Get Psychiatric Alert (Update2): London-based AstraZeneca Plc’s Accolate and Cary, North Carolina-based Cornerstone Therapeutics Inc.’s Zyflo, both asthma drugs, also will have to change their labels. Singulair is Merck’s top-selling medicine, with $4.33 billion in revenue last year.
Dr Reddy's expands horizon: Last week, DRL also received success in the anti-asthmatic segment. After a US court set aside the plea by AstraZeneca that markets Accolate (Zafirlukast), the Food and Drug Administration (USFDA) gave its nod to DRL for the launch of Zafirlukast generics.
Strativa Pharma Signs Agreement With Swedish Orphan Biovitrum - Quick Facts: (RTTNews) - Strativa Pharmaceuticals, the proprietary products unit of a wholly owned subsidiary of Par Pharmaceutical Co., Inc. (PRX: News ) Tuesday said it has entered into an amended and restated license and supply deal with Swedish Orphan Biovitrum ...
Dr. Reddy's announces the Launch of Zafirlukast Tablets: rdy /quotes/nls/rdy ( RDY 35.64 , -0.10 , -0.28% ) announced today that it has launched Zafirlukast tablets (10 mg and 20 mg), a bioequivalent generic version of Accolate(R) in the US market. On November 15, 2010 the U.S. District Court of New Jersey ...

Par indgår distributionsaftale med AstraZeneca for generiske Accolate: Par Pharmaceutical Companies, Inc. (NYSE: PRX) har i dag annonceret at de har indgået en eksklusiv levering og distribution aftale med AstraZeneca i USA for at distribuere den godkendte generiske version af AstraZenecas Accolate ® (zafirlukast). Par ...
Par Pharmaceutical Begins Shipment of Generic Accolate®: WOODCLIFF LAKE, N.J. , Nov. 22, 2010 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX - News ) today announced that it has entered into an exclusive supply and distribution agreement with AstraZeneca in the U.S. to distribute the authorized ...
Side Effects of Accolate: Accolate is a drug used to prevent asthma attacks. The drug will not put a stop to actual asthma attacks. Certain chemicals in the body such as leukotrine are known for starting asthma attacks. Accolate ...
Buy Dr Reddy’s With Stop Loss Of Rs 1400: regulators to roll out the generic edition of AstraZeneca's Accolate, which is used to treat asthma. At present, Dr Reddy's is working on manufacturing plans for zafirlukast (Accolate's generic name), and will settled ...
Dr Reddys Labs a mkt performer: Karvy Stock Broking: Accolate would have an upside of Rs 2.5 for the six month period. We value the EPS upside of Rs 17.1 at 5x and add Rs 86 to the company's core value of Rs 1450 and arrive at a price target of Rs 1536. We upgrade the ...
InterfaceFLOR Awarded for „Germany’s Most Sustainable Recycling“: The accolate under the patronage of Chancellor Dr. Angela Merkel is presented to companies that consistently and extensively implement the principles of sustainability throughout their business to a high standard. The 14 members of the jury were ...
Asthma Medication Evaluated for Possible Link to Behavior/Mood Changes ...: The FDA is also reviewing postmarketing reports of behavior/mood changes, suicidality, and suicide in other leukotriene-modifying medications, including zafirlukast (Accolate, AstraZeneca), also a leukotriene-receptor antagonist, and zileuton (Zyflo ...
FDA says Singulair data do not suggest suicide link: "Although these data do not suggest that montelukast, zafirlukast or zileuton are associated with suicide or suicidal behavior, these clinical trials were not designed specifically to examine neuropsychiatric events," the FDA said. "As a result, some ...
Merck, AstraZeneca Asthma Drugs Get Psychiatric Alert (Update2): London-based AstraZeneca Plc’s Accolate and Cary, North Carolina-based Cornerstone Therapeutics Inc.’s Zyflo, both asthma drugs, also will have to change their labels. Singulair is Merck’s top-selling medicine, with $4.33 billion in revenue ...
Polish engineer's refusal to convert costs him his life (Feature): Only an accolate of such a satanistic cult could defend the death of such a brave man. All sould understand that muslimes are an evil that needs to be destroyed. They lie and decieve as a matter of course, we should feel no mercy towards them. We ...

Do you need an Accolate lawyer in District of Columbia? Contact one of our Accolate lawyers in District of Columbia now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Need An Accolate Attorney?

First Name Last Name Email Address State

Legal Issue

FDA Drug Database: Accolate Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Accolate Information

Click to View Our Legal Resources

Do you need an Accolate lawyer in District of Columbia? Contact one of our Accolate lawyers in District of Columbia now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120517-110805

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

FDA Drug Database: Accolate Click to select a Legal Issue

Close (x)

Find Legal Help for Your Accolate Case - Submit Your Information Below

Do you need legal assistance with your Accolate case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * FDA Drug Database: Accolate Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.